相关实验视频

Updated: Jul 16, 2025

Using Optical Coherence Tomography and Optokinetic Response As Structural and Functional Visual System Readouts in Mice and Rats

Using Optical Coherence Tomography and Optokinetic Response As Structural and Functional Visual System Readouts in Mice and Rats

Published on: January 10, 2019

基于长期结果的BVO-ME治疗策略,通过OCT图像和视觉敏度对视网膜结构进行相关联

Yuki Hattori¹, Ryo Fujiwara², Hidetsugu Mori²

¹Department of Ophthalmology, Kansai Medical University, 2-5-1 Shinmachi, Hirakata, Osaka, 573-1191, Japan. hattoyuk@hirakata.kmu.ac.jp.

BMC ophthalmology

|September 19, 2023

概括

完整的视网膜结构,如EZ带和凸,对视网膜静脉封闭的患者来说,长期预测更好的视力敏度. 经常出现的脑下液会对视力产生负面影响,强调需要持续治疗.

科学领域:

眼科医生眼科眼科
视网膜疾病视网膜疾病
血管医学血管医学

背景情况:

内抗血管内皮生长因子 (VEGF) 注射是治疗分支视网膜静脉封闭 (BVO-ME) 继发的黄斑的标准.
现有的研究主要集中在针对BVO-ME的抗VEGF治疗的短期结果上.
对于BVO-ME视觉结果的长期预后指标仍未得到充分研究.

研究的目的:

为了识别BVO-ME患者的视觉预后的长期指标,这些患者接受了内抗VEGF治疗.
调查视网膜结构完整性之间的相关性,通过光学一致性断层扫描 (OCT) 评估,和长期视力敏度.

主要方法:

在堪萨伊医科大学医院 (2012年6月 - 2022年3月) 用内抗VEGF治疗的BVO-ME患者的回顾性分析.
纳入标准:抗VEGF的第一线治疗,至少36个月的随访.
排除标准:其他眼部疾病,先前的BVO-ME治疗. 根据最终最佳校正视敏度 (BCVA) 分类的患者.

主要成果:

分析了45名患者的47只眼睛,平均随访时间为64.38个月.
带有完整的EZ带和凸的眼睛显示出明显更好的视力敏度.
在具有更好的长期视觉结果的眼睛中观察到下液 (SRD) 的复发率较低.

结论:

在BVO-ME.中,EZ带和凸的完整性是长期视力敏度的重要预测指标.
复发性SRD与较差的长期视觉预后有关,即使最初的视力敏度很好.
长期的结构完整性对于BVO-ME.的持续视觉功能至关重要.

关键词:

这就是BRVOVO BRVOVO.在CME中,CME是CME.这是一个很好的选择.叶突起叶突起内抗VEGF治疗的治疗方法这是一个SRD,SRD是SRD.

更多相关视频

Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Published on: May 26, 2023

Optimization of the Retinal Vein Occlusion Mouse Model to Limit Variability

Optimization of the Retinal Vein Occlusion Mouse Model to Limit Variability

Published on: August 6, 2021

相关概念视频

Open Angle Glaucoma: Treatment

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

Angle Closure Glaucoma: Treatment

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...